Recently, sponsored by Securities Times and China Fund News, the Seventh Tianma Prize of “ Gathering power and seeing future” was grandly held. Huadong Medicine Board of Directors was awarded the prize of “ the best board of directors of China's mainland-listed companies”.
Since the listing, the securities office of the company has done a good job of communication and interaction with investors and information disclosure. The company's investor relations management work has been highly recognized by regulators, media and investors. The board of directors of the company will learn from the experience of other outstanding listed companies, continue to promote the standardized operation of the company, and promote the sustainable and steady development of the company.